List of Devices Companies in Canada - 40

7D Surgical is a privately-owned Toronto based company that develops advanced optical technologies and machine vision-based registration algorithms to improve surgical workflow and patient care. 7D Surgical's flagship FLASH Navigation System delivers profound improvement to surgical workflows in spine surgery, providing the promise of similar future advancements in other surgical specialties.

ARC Medical Inc. is committed to improving the quality of life for people who have undergone surgery by developing safer and more effective innovative fluid medical devices that prevent the formation of surgical adhesions.

Cardiovascular solutions without compromise. BioIntegral Surgical, Inc. is focused on all-biological cardiovascular implants which are designed to last the lifetime of the patient. All BioIntegral Surgical devices are backed by a lifetime warranty, the only of its kind in the medical device industry. Balancing the most durable designs, biocompatible materials and quickest to implant devices, the implants are meant to eliminate the ordinary compromises and short-comings of other devices. Other devices don’t have permanently fixed tissue, leach toxic residuals, use synthetic materials or have cheaper-to-manufacture designs which compromise the redistribution of force and longevity. Company core values ------------------------------ Excellence. We commit to make the best, high-quality devices available globally Initiative. We value initiative to improve the capabilities of the company although not at the expense of quality Integrity. We strive for integrity in our decisions and products Ownership. We instill a sense of ownership for each employee Education. We aim to educate each other so we can make the best decisions and produce the best results together

Breathe BioMedical® is developing an innovative breath analytics platform to enable the early detection of disease. Our proprietary breath analytics technology is designed to collect, process and analyze breath samples to identify biomarker patterns associated with specific diseases. Breathe BioMedical is focused first on implementing a new breath test for breast cancer detection for women with dense breast tissue, as an adjunct to mammography, with the goal of increasing the number of breast cancer cases identified at the earliest stages. One day, detecting disease may be as easy as breathing.

Headquartered in Kickland, Quebec, ChitogenX Inc. (formally Ortho Regenerative Technologies Inc.) is a clinical stage regenerative medicine company dedicated to the development of novel therapeutic tissue repair technologies to improve tissue healing. The Company is committed to the clinical development of its proprietary RESTORE technology platform, a muco-adhesive CHITOSAN based biopolymer matrix, specifically designed to deliver biologics such as platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC), to enhance healing in various musculoskeletal conditions. ORTHO-R, its lead Chitosan-PRP hybrid biologic implant combination product, is formulated and designed to increase the healing rates of occupational and sports related injuries to tendons, ligaments, and cartilage such as the meniscus. ORTHO-R can be directly and easily applied to the site of injury by a surgeon during a routine operative procedure with minimal disruption to length of surgery. ORTHO-R is currently the object of an ongoing U.S. Phase I/II clinical trial for rotator cuff tear repair in 10 U.S. based clinical centers. Other formulations are being developed to leverage the technology's performance characteristics such as tissue adhesion, pliability, and ability to deliver biologics or therapeutics to various tissues damaged by trauma or disease. Further information about Chitogenx is available on the Company's website at www.chitogenx.com and on SEDAR at www.sedar.com.

Diros Technology Inc. is a world leader in the development and commercialization of Radiofrequency RF devices for Pain Management and Neurosurgery. The principals of Diros Technology Inc. have been at the forefront of Radiofrequency (RF) since the establishment of the OWL® brand in 1969. Diros was founded in 1983 to continue the advancement of new and innovative RF Products.

Everest Clinical Research ("Everest"​) is a full-service contract research organization (CRO) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. We serve some of the best-known companies and work with many of the most advanced drugs, biologics, and medical devices in development today. Everest has been an independent CRO since 2004 with a strong foundation as a statistical and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Operating primarily in North America, with headquarters located in Markham, Ontario, Canada, with additional offices in Little Falls (Greater New York City Area), New Jersey, USA, and Shanghai, China. Everest is known in the industry for its high quality deliverables, superior customer service, and flexibility in meeting clients' needs. A dynamic organization with an entrepreneurial origin, Everest continues to experience exceptional growth and great success Quality is our backbone, customer-focus is our tradition, flexibility is our strength...that's us…that's Everest! Important Information for job candidates: Please be aware of cyber-security due to some fraudulent job scams. Everest will follow our standard and thorough recruitment process which will include video panel interviews: https://www.ecrscorp.com/recruitment-process/ Everest email communication will come from an ecrscorp.com email address. Emails from other domains may not be from Everest. Everest will never ask for credit card information or charge fees at any time during the recruitment process. If something is portrayed as Everest but does not appear to be from Everest, please feel free to contact us at https://www.ecrscorp.com/contact/

Fluid Biomed is a medical device start-up founded by two neurosurgeons at the University of Calgary that has developed an implantable dissolving stent to divert blood flow and heal blood vessels. The desire to innovate and create positive change has always been a priority for the founders and inventors, Dr. John Wong and Dr. Alim Mitha. Working together for the past 18 years to help people with stroke, their drive and commitment to improve patient health sparked a vision to create a radical new stent to cure brain aneurysms without invasive surgery.

We are Gemina Labs, a point-of-care test developer with a proprietary breakthrough chemistry platform. Founded in 2020, the Gemina chemistry platform is an advanced, “universal” bio-sensing toolkit that enables a new generation of diagnostic tests for infectious diseases and beyond. The chemistry platform isn’t just high-performing. It also overcomes many supply chain accuracy bottlenecks in the sector and cuts the development time for prototype tests to weeks. Best of all, the platform empowers “quantitative testing” (not just positive/negative tests) that opens up new applications in personal well-being (stress, fatigue monitoring etc.)

Based on world-leading technology, we are developing a unique ultrasound helmet that is as portable as it is precise. Our first disease target: Alzheimer’s disease.

Clinical Development Solutions (CDS) is a Contract Research Organization providing strategic drug development, clinical trial, regulatory, pharmacovigilance and quality assurance consulting to biotechnology, pharmaceutical and medical device companies. CDS understands the unique needs of small companies. With our North American regulatory expertise, we can add value and efficiency to your clinical trials and FDA and Health Canada interactions. Our strategies will help you get proof of concept established earlier and new products and indications to market faster. CDS offers complete clinical trial management services in Canada and the US including site selection, monitoring, quality assurance, project management and post-market pharmacovigilance. CDS will be a valuable collaborator with your emerging life science or medical device company.

HALIFAX BIOMEDICAL INC. (HBI) is a biomedical company focused on the delivery of contract research services and the development of diagnostic medical equipment. We are the only company worldwide currently providing a complete product and service solution for RSA. We support the fundamental principles of phased innovation - the practice of clinically testing products before general market release.

Innodem Neurosciences is committed to improving the effectiveness and quality of life and care of patients with neurological problems. Innodem works with the pharmaceutical industry, leading medical professionals, and artificial intelligence experts to develop and promote Eye Movement Biomarkers (EMBs) & Gaze Mapping Biomarkers (GMBs) as important clinical assessment tools in the field of neurology. It is building a series of disease-specific tests embodied in an intuitive App that captures EMB & GMB data. The vision is that over time, while leveraging the latest advances in machine and deep learning, this EMB/GMB platform will assist users to accurately diagnose and monitor neurological disorders affecting eye-movements or cognition such as multiple sclerosis, Alzheirmer's, Parkinson's or related disorders, Frontotemporal dementia, Cancer-related cognitive impairment (Chemo Brain) and many others.

Innovotech is a pioneer in the field of biofilm product development, focused on providing innovative and practical solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are organized communities of microorganisms that exist in virtually every natural environment and are responsible for a host of diseases in human health, animal health and agriculture. Innovotech has a broad range of products that address the issue of biofilms within a number of different industries, including commercially available products in three market segments; the MBEC Assay™, bioFILM PA™ and InnovoSCEPT veterinary kits. The MBEC Assay™ is a high throughput biofilm growth device that was recently approved as an ASTM International standard. bioFILM PA™ is the first diagnostic kit to assist physicians in the selection of the most effective combination antibiotic treatment of patients with biofilm-based chronic lung infections, while the InnovoSCEPT veterinary kits are designed to determine the most effective antibiotic treatment for infections in both large and small animals. Innovotech also has two products in advanced stages of development; Agress® is a unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections and Sani-Lux™ is a light-activated, natural hard surface sanitizer.

Insight Medbotics is developing MRI-guided robotics to bring together the insights only MRI can provide with the minimally invasive access and precision of robotics. Our MRI-compatible robot, IGAR, has been clinically demonstrated. As the only company to receive a FDA 510(k) clearance for use of a robot inside an MRI, Insight Medbotics is now advancing the technology to improve the standard of care for prostate cancer. Our vision is to bring our advanced MRI-guided robotic technology to procedures where accuracy and precision matter most to patients, physicians and hospitals.

Laborie is a world-class specialist medical company that makes and advances technologies that preserve and restore human dignity. We take great pride in supporting doctors, nurses, hospitals, clinics, academic institutions and patients with treatment and diagnostic innovations. Our technologies include diagnostic equipment and consumable supplies in the Urology, Gastroenterology, Gynecology, Obstetrics and Neonatology fields. Privately owned by Patricia Industries and a part of the Investor AB network, Laborie is comprised of powerful brands that have been cultivated for more than 50 years. As a rapidly growing and scaling organization, our company values drive our day-to-day behaviors and make us ONE Laborie whenever and wherever we do business. We know that the work we do matters and we’re making a positive impact in the lives of patients across the globe. This is what fuels our motivation each day. If you’re ready to be part of a mission with meaning and a rewarding environment with opportunities for professional growth and career advancement, view our current job openings at https://laborie.bamboohr.com/jobs/ and apply online.

Microbix Biosystems Inc. develops and commercializes proprietary biological and technological solutions for human health and wellbeing. We manufacture a wide range of biological materials for the global diagnostics industry, notably antigens used in immunoassays and Quality Assessment Products (QAPs™). In 2021 we launched our first Viral Transport Medium, branded as DxTM. Microbix’s business of producing high-quality viral and bacterial preparations stems from over three decades of experience in the field, including strain selection, reliable and efficient organism culture at scale, purification, and pathogen inactivation. As a result of Microbix’s expertise, its products have received widespread and longstanding customer acceptance, with continuing growth in demand. Microbix’s current catalogue of biological preparations covers a range of pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually transmitted, and insect-borne diseases. Microbix also applies its biological expertise to develop other innovative and proprietary technologies and products. Our development project pipeline currently includes Kinlytic® Urokinase, a biologic thrombolytic drug used to treat blood clots.

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

Noze is the global leader in digital odor perception (often hailed as the digital equivalent of the sense of smell). We have developed the world's most advanced digital nose, capable of detecting and identifying odors in real-world settings with unparalleled accuracy. Leveraging cutting-edge machine intelligence and a sensor developed with exclusively licensed NASA technology, Noze is committed to enhancing human health and wellbeing. Our mission is to improve patient outcomes by enabling real-time disease detection at any point-of-care by using our technology to target breath-based odor biomarkers.

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. The company has created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.

Pro-Lab Diagnostics is a privately held corporation founded in 1974. The head office is located in Ontario, Canada, with subsidiaries in the United Kingdom and the United States of America. Pro-Lab Diagnostics is registered under ISO 13585:2003 (CMDCAS) as well as with both the Therapeutic Products Directorate (TPD) of Health Canada and the Food and Drug Administration (FDA) of the United States. Pro-Lab's mission is to deliver today, and research for tomorrow. This is accomplished through extensive onsite research and development, leading to the manufacture of high quality and cost effective immunodiagnostic reagents. Additionally, Pro-Lab distributes a wide array of innovative products sourced from leading companies from around the globe. Disciplines covered include Clinical Microbiology, Molecular Biology, Transfusion Medicine, Instrumentation, Women's Health, Laboratory Ware, and much more. Pro-Lab also specializes in OEM (private label) packaging and welcomes new business opportunities. To find out more about Pro-Lab Diagnostics and its product offering, please visit our website at www.pro-lab.com.

PulseMedica has developed a proprietary real-time 3D imaging and laser targeting system for precise retinal surgery. Our patented next generation ultrafast femtosecond laser ophthalmic treatment will enable treatment for retinal diseases such as age-related macular degeneration (AMD) and glaucoma, for which there is currently no cure. PulseMedica is a company based out of Edmonton, AB, Canada.

A Canadian based medical device company building world's first minimally invasive heart pump for patients with advanced heart failure.

Radialis is advancing precision medicine by providing the next generation of organ-targeted positron emission tomography (PET).

Regulatory Heights is a regulatory consulting company that offers quality, clinical, pharmacovigilance, and medical information consulting services to corporations in the medical and consumer product supply chain.

At Rehabtronics, we make technology to help people recover from neurological injuries like stroke and spinal cord injury. Our products include the ReJoyce and ReTouch workstations for upper extremity rehabilitation, and the ReGrasp nerve stimulator for hand movement.

RepliCel Life Sciences Inc. is leading a revolution in the development of products for sports medicine and aesthetics. We are a regenerative medicine company developing innovative, clinical-stage technologies for unparalleled skin rejuvenation, tendon regeneration, and hair regrowth. RepliCel is currently involved in three clinical development programs: RCT-01 for treatment of Achilles tendinosis, RCS-01 for skin rejuvenation, and RCH-01 for treatment of Androgenic Alopecia. In Asia, RCH-01 is the subject of a co-development partnership with cosmetics and skincare giant Shiseido Company, Limited. Shiseido is currently funding a clinical study for the treatment of male and female pattern baldness (androgenic alopecia) in Japan with data anticipated in late 2018. RepliCel's nearest-term commercial asset is its next-generation dermal injector, RCI-02 which represents a medical device bringing unparalleled precision and consistency to dermal injections including shallow, even dispersion of dermal fillers for fine wrinkles. RCI-02 also promises to obviate the need for local anesthetic injections due to its patented skin-numbing element embedded in the device.

Satisfai Health is on a mission to create the most comprehensive AI solution for gastrointestinal (GI) practice and research. To realize this vision, we aim to enhance the quality, speed, and affordability of existing methods for the detection, diagnosis, assessment and treatment of disease. Satisfai Health's AI products cover a range of applications in Upper and Lower GI, delivering innovative measurement, tracking and reporting on the most important clinical findings. Our core focus is enhancing human experiences. Through technology, we deliver personalized and precise approaches that benefit both caregivers and patients. Our solutions are used by pharmaceutical companies and contract research organizations in the drug development process, and will be used by practicing GI physicians in clinical practice. Our team is composed of highly experienced physicians, data scientists, software engineers and healthcare business professionals. We work with a network of globally recognized scientific and clinical experts, and are fortunate to be supported by some of the world's leading venture capital and private equity groups. We are growing quickly and always looking to add high quality talent in the right areas.

Sernova (TSX: SVA) (OTCQB: SEOVF) is a clinical-stage biotechnology company that is advancing a novel cell therapy platform for the treatment of chronic diseases. Our lead program is evaluating our Cell Pouch System™ as a potential ‘functional cure’ for insulin-dependent diabetes. In addition, we have a robust pipeline that includes preclinical programs in hemophilia A and hypothyroidism.

Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The company's flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.

SoundBite is a medical devices start-up, Montreal and Sherbrooke-based, developing and commercializing proprietary shockwave device and generator technology delivered within the cardiovascular system to treat chronic total occlusions (CTO's). The company will target CTO's in patients with peripheral artery disease (PAD) and coronary artery disease (CAD), disease states that affect over 12 million and 8 million Americans, respectively.

Sound Blade Medical is developing a compact ultrasound therapy platform that will allow a variety of pathologies to be treated non-invasively with unparalleled precision.

Spiderwortisdeveloping a novel biomaterial that will offer new avenues in 3D in vitro research and in regenerative medicineusing plant derived cellulose to create a variety of scaffold architectures.

Headquartered in Ontario, Canada, SpinaFX is working to introduce minimally invasive, image-guided solutions to the market that benefit patients, physicians, facilities and payers. SpinaFX Medical's flagship treatment solution involves the intravertebral injection of a mixture of oxygen and ozone gas into a contained herniated disc for relief of back and leg pain. This technology is not currently approved for sale by regulatory agencies in the U.S., Canada, EU or elsewhere.

StarFish Medical provides award-winning design, development, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Cardiovascular, Digital Health, IVD, Ophthalmology, Optics, Ultrasound, POC Assay Diagnostic Technologies, and Microfluidics. StarFish expertise includes electronics, mechanical, human factors and software systems engineering. Our proprietary Pathfinder™ process for medical device product definition saves clients time and resources throughout the technology and product development phases to commercialization. Prototype and low volume complex electro-mechanical production are delivered in ISO 13485 certified facilities with cleanroom capabilities in Toronto and Victoria Regulatory and quality system (QMS) consultants at StarFish provide technical regulatory assistance for FDA and Health Canada submissions, including IEC 60601 and ISO13485. Innovative Design and Development  Electronic / software / mechanical engineering  Industrial design / human factors engineering  PathfinderTM product definition process  Technology optimization  Verification / validation / testing  ISO 13485 certified QMS Integrated Manufacturing  Seamless ramp from clinical trials to full production  Deep engineering involvement & oversight  Electro-mechanical / software expertise  Customized cart specialists  Optical instrument build and test  Dedicated program manager Flexible Manufacturing  New product introductions  Supply-chain management  North America facilities  Depot repair & field service  Sustaining / value engineering  Class 100,000 cleanroom

Interested in working at Synex? Connect with us https://careers.synexmedical.com/ Our mission is to make predictive health a reality by providing accurate and non-invasive monitoring at the molecular level. Non-invasive glucose monitoring has been sought after for decades. Many people have tried. None have succeeded. Our novel approach to solving and going beyond this challenge will enable a future of true predictive healthcare. We’re looking for passionate and exceptionally talented people who want to be part of the team that achieves this vision.

Tenomix is a medical technology company focused on developing novel technologies to target inefficiencies in the pathology workflow and optimize cancer care. Their vision is to be at the forefront of pathology innovation, ensuring pathology staff are equipped with the right tools that help in battling cancer. Tenomix has also secured significant funding for their innovative solutions in cancer care.

Theralase® is focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive applications. The company is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light-activated Photo Dynamic Compounds (PDCs) for the treatment of various cancers. Theralase® was one of the first companies in North America to develop personalized anti-cancer therapy and cool laser therapy.

uFluidix specializes in manufacturing silicone (PDMS) and thermoplastic (PMMA, PC, PS, COC, and COP) microfluidic chips and devices for microtechnology applications. Our expertise in the development and processing of these micro-featured components goes beyond the know-how of most of the plastic industry, who use conventional molding, stamping or rolling technologies. Our two differentiators are: 1. We affordably fabricate plastic parts with features accurate within +/- 0.5um if needed. 2. We bond or laminate hard-to-bond parts with less than 1% distortion of their sensitive micro-features. Over 10 years of experience has rewarded uFluidix with knowledge proven to be useful for a wide range of applications. If you are currently conceptualizing, improving, or validating an application from the list below we invite you to a friendly chat with one of our development specialists. We ensure you would hear something from us that is worth the experience. Applications: • Point-of-Care Blood/Urine Analysis Cartridges • Complicated Micro Arrays • Tissue Engineering Scaffolds • Customized Cell Culture Systems • Opto-electrical Methods • Point-of-Care Biomarker Detection • Pathogen Detection in Human/Animal • Optical-MEMS • Toxicity Measurements in Droplet Samples • Drug Efficacy Monitoring in Tiny Body Fluids • Cell Separation • Benchtop Cell Count Measurement • Fluidic Drug Delivery • Cancer Research via Biomarker or Cell Analysis • In-Vitro Platforms for Stem Cell Research • Selective Methods for Fertility Aid • Microfluidic Systems • Point-of-Care Sequencing Solutions • Portable Forensic Devices https://www.ufluidix.com/microfluidics-applications/ Any questions? Please visit ufluidix.com or email us at info@ufluidix.com

Zilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, with an initial focus on ocular oximetry.